The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs
Abstract
During the past decade, the price of cancer drugs and the spending for cancer treatments by Medicare have increased dramatically. The author outlines the usual tools Medicare uses to control its spending on drugs and discusses the policies that make cancer drugs a special case and prohibit the regulation of their prices and utilization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Chemotherapy and the war on cancer
Chabner, B. A., & Roberts, T. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1529 · Cited by 2,154
The Price Tag on Progress — Chemotherapy for Colorectal Cancer
Schrag, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048143 · Cited by 436
Cost of Cancer Care: Issues and Implications
Meropol, N. J., & Schulman, K. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6081 · Cited by 351
Economics of New Oncology Drug Development
DiMasi, J. A., & Grabowski, H. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0803 · Cited by 348
Lohr, K. N., Brook, R. H., KAMBERG, C. J., Goldberg, G. A., Leibowitz, A. A., KEESEY, J. W., Reboussin, D. M., & Newhouse, J. P. (1986) · PubMed · Cited by 346
Medical Oncologists' Views on Communicating With Patients About Chemotherapy Costs: A Pilot Survey
Schrag, D., & Hanger, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2437 · Cited by 194
Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors
Schneeweiss, S., Walker, A. M., Glynn, R. J., Maclure, M., Dormuth, C., & Soumerai, S. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa003087 · Cited by 178
Fundamental Reform of Payment for Adult Primary Care: Comprehensive Payment for Comprehensive Care
Goroll, A. H., Berenson, R. A., Schoenbaum, S. C., & Gardner, L. B. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0083-2 · Cited by 176
Does Reimbursement Influence Chemotherapy Treatment For Cancer Patients?
Jacobson, M., O’Malley, A. J., Earle, C. C., Pakes, J., Gaccione, P., & Newhouse, J. P. (2006) · Health Affairs · doi:10.1377/hlthaff.25.2.437 · Cited by 136
Developing A Center For Comparative Effectiveness Information
Wilensky, G. R. (2006) · Health Affairs · doi:10.1377/hlthaff.25.w572 · Cited by 134
Steinbrook, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0806862 · Cited by 99
The Effect of Prospective Payment on Medicare Expenditures
Russell, L. B., & Manning, C. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902163200706 · Cited by 88
Weight, C., Klein, E. A., & Jones, J. S. (2008) · Cancer · doi:10.1002/cncr.23421 · Cited by 80
Tier 4 Drugs and the Fraying of the Social Compact
Lee, T. H.-Y., & Emanuel, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0804261 · Cited by 67
Medicare Prospective Payment and the Shaping of U.S. Health Care
Mayes, R. (2008) · Johns Hopkins University Press eBooks · doi:10.1353/book.3236 · Cited by 55
Access To Cancer Drugs In Medicare Part D: Formulary Placement And Beneficiary Cost Sharing In 2006
Bowman, J., Rousseau, A., Silk, D., et al. (2006) · Health Affairs · doi:10.1377/hlthaff.25.5.1240 · Cited by 26
The Expanding Pharmaceutical Arsenal in the War on Cancer
Lichtenberg, F. R. (2004) · National Bureau of Economic Research · doi:10.3386/w10328 · Cited by 23
Cited by
Projections of the cost of cancer care in the United States: 2010–2020
Mariotto, A. B., Robin Yabroff, K., Shao, Y., Feuer, E. J., & Brown, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq495 · Cited by 2,657
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Basch, E., Prestrud, A. A., Hesketh, P. J., Kris, M. G., Feyer, P. C., Somerfield, M. R., Chesney, M., Clark-Snow, R. A., Flaherty, A. M., Freundlich, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4614 · Cited by 1,059
Carrera, P. M., Kantarjian, H. M., & Blinder, V. S. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21443 · Cited by 876
Medical Care Costs Associated with Cancer Survivorship in the United States
Mariotto, A. B., Enewold, L., Zhao, J., Zeruto, C. A., & Yabroff, K. R. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1534 · Cited by 634
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Hesketh, P. J., Kris, M. G., Basch, E., Bohlke, K., Barbour, S. Y., Clark-Snow, R. A., Danso, M. A., Dennis, K., Dupuis, L. L., Dusetzina, S. B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.4789 · Cited by 628
Metadata
- Authors
- Bach, P. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-02-05
- Volume
- 360
- Issue
- 6
- Pages
- 626-633
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132047269
- Cited by
- 390
- References
- 20
- FWCI
- 69.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.